Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/25 18:07 | 2/19/25 | NKTR | Health | Drug | Pharmaceutical Preparations | Zalevsky Jonathan | CA | O | Chief R, | 2 | S | -58 | 0.9517 | 0 | -61 | 327 | D | |||||||||||||||
2/21/25 18:06 | 2/19/25 | NKTR | Health | Drug | Pharmaceutical Preparations | Wilson Mark Andrew | CA | O | GC | 2 | S.m | -56 | 0.9172 | 0 | -61 | 335 | D | |||||||||||||||
2/21/25 18:04 | 2/19/25 | NKTR | Health | Drug | Pharmaceutical Preparations | Robin Howard W | CA | DO | P,CEO | 2 | S.m | -156 | 0.9991 | 0 | -156 | 1,111 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |